Transcranial Direct Current Stimulation Systems Sales Market
Transcranial Direct Current Stimulation Systems Sales Market
Segments - Global Transcranial Direct Current Stimulation Systems Sales Market Types (Transcranial Direct Current Stimulation, Transcranial Alternating Current Stimulation, Transcranial Pulsed Current Stimulation, and Transcranial Random Noise Stimulation), Applications (Hospital, Clinic, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028
Upcoming
| Report ID :ICT-SE-4246
| 4.2 Rating
| 84 Reviews
| 176 Pages
| Format :
Report Description
The global transcranial direct current stimulation systems sales market size is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Transcranial direct current stimulation (tDCS) systems are primarily used to stimulate the brain of patients by using electric current. The methods are non-invasive, safe, and painless techniques that help to offer brain stimulation treatment for patients suffering from neuropsychiatric diseases. The system deploys two types of simulation techniques namely cathodal and anodal stimulation. The cathodal stimulation assists in reducing irregular neuronal activities while anodal stimulation helps in activating the functioning of neurons in the brain. Using these systems, a patient can enhance his or her cognitive functions such as memory skills and improve language learning abilities. With the introduction of innovative technology, patients with developmental disorders or illnesses can be properly treated with TDCS therapy, which has boosted the overall market revenue.
Market Trends, Drivers, Restraints, and Opportunities:
- Wide prevalence of neuropsychiatric diseases such as Parkinson's disease that cause depression and anxiety among a large number of the global population is a key factor driving the market.
- Ongoing research and development programs and development of new technology that ensure cognitive improvement in some patients undergoing tDCS present another key drivers of the market.
- Side effect of using tDCS methods such as slight itching or tingling on the scalp is a major challenge that can restrain the growth for the market during the forecast period.
- Availability of affordable, non-invasive, painless, and safe tDCS methods for treatment of various neuropsychiatric disorders are expected to boost the market in the coming years.
Scope of the report
The report on the global transcranial direct current stimulation systems sales market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
| Attributes | Details |
| Report Title | Transcranial Direct Current Stimulation Systems Sales Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018 & 2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types (Transcranial Direct Current Stimulation, Transcranial Alternating Current Stimulation, Transcranial Pulsed Current Stimulation, and Transcranial Random Noise Stimulation), Applications (Hospital, Clinic, and Others) |
| Regional Scope | Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
| Report Coverage | Market Scope, Analysis, Share, Competitive Analysis, Growth Facts, Restraints, Opportunities, and Revenue Forecast |
| Key Players Covered | Magstim, neurocare group AG, Newronika S.p.A., Brainbox Ltd, Soterix Medical Inc., and Shenzhen Yingchi Technology Co. Ltd. |
Transcranial Direct Current Stimulation Systems Sales Market Segment Insights
Transcranial direct current stimulation segment to hold significant market share
In the terms of types, the transcranial direct current stimulation systems sales market is categorized as transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), transcranial pulsed current stimulation (tPCS), and transcranial random noise stimulation (tRNS). The transcranial direct current stimulation segment held considerable share of the market in 2020 and is projected to hold significant market share in the coming years. The segment growth is attributed to wide incidence of brain-related illness among a large number of the ageing population worldwide and the extensive adoption of the simulation system for the treatment of such illness including chronic pain and anxiety problems.
Hospitals segment to grow rapidly
On the basis of applications, the market is segregated into hospital, clinic and others. Among the end-users, the hospitals segment is expected to grow rapidly during the forecast period owing to the availability of well-developed medical facilities that offer effective treatment for people with long-term and short-term ailments. Hospitals are among the first healthcare institutes that start implementing tDCS treatment for neuropsychiatric patients. Moreover, many tDCS devices are widely used in hospitals for the treatment of neurological disorders such as depression, epilepsy, and other mental disabilities. However, the clinic segment is projected to register a high CAGR during the forecast period owing to massive investment in clinical experiments for testing innovative technology for the treatment. Moreover, easy accessibility of clinics and presence of specialized clinical centers present another key aspect for the segment growth.
North America to dominate the global market
In terms of regions, the transcranial direct current stimulation systems sales market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the market during the forecast period owing to increasing investment in healthcare stimulation systems. Moreover, the presence of large number of patients suffering from brain degenerated diseases especially in the United States and Canada present another key driver of the regional market. The increasing governments’ investment in the overall healthcare facilities and infrastructures is expected to further boost the regional market.
Segments
By Types
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Alternating Current Stimulation (tACS)
- Transcranial Pulsed Current Stimulation (tPCS)
- Transcranial Random Noise Stimulation (tRNS)
- Hospital
- Clinic
- Others
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
- Magstim
- Neurocare group AG
- Newronika S.p.A.
- Brainbox Ltd
- Soterix Medical Inc.
- Shenzhen Yingchi Technology Co. Ltd.
Competitive Landscape
Key players in the global transcranial direct current stimulation systems sales market are Magstim, neurocare group AG, Newronika S.p.A., Brainbox Ltd, Soterix Medical Inc., and Shenzhen Yingchi Technology Co. Ltd. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcranial Direct Current Stimulation Systems Sales Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transcranial Direct Current Stimulation Systems Sales Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transcranial Direct Current Stimulation Systems Sales Market - Supply Chain
4.5. Global Transcranial Direct Current Stimulation Systems Sales Market Forecast
4.5.1. Transcranial Direct Current Stimulation Systems Sales Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transcranial Direct Current Stimulation Systems Sales Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Transcranial Direct Current Stimulation Systems Sales Market Absolute $ Opportunity
5. Global Transcranial Direct Current Stimulation Systems Sales Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Transcranial Direct Current Stimulation Systems Sales Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Transcranial Direct Current Stimulation Systems Sales Demand Share Forecast, 2019-2026
6. North America Transcranial Direct Current Stimulation Systems Sales Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Transcranial Direct Current Stimulation Systems Sales Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Transcranial Direct Current Stimulation Systems Sales Demand Share Forecast, 2019-2026
7. Latin America Transcranial Direct Current Stimulation Systems Sales Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Transcranial Direct Current Stimulation Systems Sales Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Transcranial Direct Current Stimulation Systems Sales Demand Share Forecast, 2019-2026
8. Europe Transcranial Direct Current Stimulation Systems Sales Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Transcranial Direct Current Stimulation Systems Sales Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Transcranial Direct Current Stimulation Systems Sales Demand Share Forecast, 2019-2026
9. Asia Pacific Transcranial Direct Current Stimulation Systems Sales Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Transcranial Direct Current Stimulation Systems Sales Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Transcranial Direct Current Stimulation Systems Sales Demand Share Forecast, 2019-2026
10. Middle East & Africa Transcranial Direct Current Stimulation Systems Sales Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Transcranial Direct Current Stimulation Systems Sales Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Transcranial Direct Current Stimulation Systems Sales Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Transcranial Direct Current Stimulation Systems Sales Market: Market Share Analysis
11.2. Transcranial Direct Current Stimulation Systems Sales Distributors and Customers
11.3. Transcranial Direct Current Stimulation Systems Sales Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Magstim
11.4.2. Neurocare group AG
11.4.3. Newronika S.p.A.
11.4.4. Brainbox Ltd
11.4.5. Soterix Medical Inc.
11.4.6. Shenzhen Yingchi Technology Co. Ltd.
Methodology
Related Reports
Some other reports from this category!
Our Clients
